CRM Watchlist 2014 Winners Review: "BPMonline Has Become More of an Impact Player"

It has become a good tradition to stay under CRM industry most prominent thought leader's vigilant eye.

2014-03-30

CHICAGO, IL, March 30, 2014 (Press-News.org) BPMonline, the world's fastest growing vendor of CRM + BPM cloud solutions, for the third year running has been recognized as the one that impacts the CRM market, as it was mentioned in Paul Greenberg's review for CRM Watchlist 2014, published on ZDNet.com.

It has become a good tradition to stay under CRM industry most prominent thought leader's vigilant eye. The 2014 is not an exception as highlighted in Paul Greenberg's recently issued review. Paul describes BPMonline as a company that 'has grown, become more of an impact player, and continues to develop what has become a superior product'.

Greenberg emphasizes BPMonline is one of the companies that sits at the top of the value chain, smart about what they do and effective in their approach. Speaking about process-based BPMonline CRM Paul Greenberg pays special attention to what was the major achievement of the 2013 - introduction of BPMonline 7.x platform with completely redesigned user interface.

"They addressed the user experience, which is a combination of look and feel, navigation, and ease of use. The result was a great, very simplified, attractive interface," says Paul in his review.

Follow the link to read the complete review __
http://www.bpmonline.com/company/news/2460

BPMonline is a global provider of first-class Customer Relationship Management and Business Process Management (BPM) solutions. Powerful and easy to use, the award-winning BPMonline CRM solution provides deep user-friendly customization at an incredibly inexpensive price point. The heart of BPMonline CRM is a business process management engine that couples a powerful set of tools for process design, with automation and analysis. Such a robust platform helps our customers meet diverse business challenges easier and at lower cost.

ELSE PRESS RELEASES FROM THIS DATE:

Jaebum Choo of Hanyang Univ. to speak at Bioanalytical Sensors Mtg, May 22-23, 2014, Cambridge, MA.

2014-03-30

Paul W. Bohn, Arthur J Schmitt Professor of Chemical & Biomolecular Engineering, University of Notre Dame, to give a presentation titled "Tight Coupling of Chemical Sensing and Reactivity in Nanofluidic Architectures" at the Inaugural Bioanalytical Sensors Conference, May 22 & 23, 2014 in Cambridge, MA. Paul Bohn received his Ph.D. in Chemistry from the University of Wisconsin-Madison. He subsequently joined the faculty at the University of Illinois at Urbana-Champaign, where he served in numerous roles, including Head of the Chemistry Department, Director of ...

MagicKitchen.com Expands Local Partner Program to North and South Carolina

2014-03-30

Today, Greg Miller, CEO of MagicKitchen.com announced a new partner in the MagicKitchen.com Local Partner Program for North and South Carolina. "Our new Partner Hearthside Home Care in Greensboro, North Carolina will represent our full line of HomeStyle and Special Diets menu items to the full spectrum of residential and commercial prepared meal customers in both North and South Carolina." said Greg Miller. MagicKitchen.com customers include Healthcare Organizations and Health Plans, specialized medical facilities such as clinics, dialysis centers, assisted living facilities, ...

Thousand Oaks Surgeon Offers Non-Surgical Facelift With JUVEDERM VOLUMA XC

2014-03-30

Renowned plastic surgeon Dr. Kouros Azar (www.azarplasticsurgery.com) is the leading injector of JUVEDERM VOLUMA XC in Thousand Oaks, where his plastic surgery practice offers the new dermal filler as an anti-aging option that doesn't require surgery. Dr. Azar was one of only 2 plastic surgeons in Southern California to receive VOLUMA XC before anyone else after it was approved by the FDA in fall 2013, and he is now one of a handful of surgeons in the region who trains other doctors in the use of the product. More patients get VOLUMA XC injections at the plastic surgeon's ...

Risk Management Executive, James Hice, Named Risk Manager and General Counsel at McCusker & Company

2014-03-30

Risk Management executive, and highly-regarded industry insider, James Hice, was today named Risk Manager and General Counsel at McCusker & Company, a leading international provider of warranty protection solutions for the commercial and consumer electronics industry. "I am pleased to name James Hice our new Risk Manager and General Counsel," said McCusker & Company Chief Executive Officer Will L. McCusker. "His connections, insight, expertise and industry knowledge will be invaluable for our company." Hice was the Vice President of Operations and Procurement ...

Envision Built Offers Custom Built Transformations of Screened Porches and Patios into Spacious Three Season Sunrooms to Extend Living Spaces in Cary, Durham and the Greater Raleigh NC Area

2014-03-30

Envision Built Home Remodeling is a custom home renovation specialist - transform your screened porch or patio into a three seasons sunroom, extending the living space of your home. Envision Built is an award-winning remodeling designer and builder. "A fairly easy way to extend the living space in your home is convert your screened porch or patio into a beautiful sunroom," said Bill Ahle, Owner of Envision Built. "Every major renovation begins with a five hour design session working with our interior designer to help you develop a plan, select color schemes and to map ...

SchureMed to Unveil Schure Loc XPS Medical Device at AORN in Chicago

2014-03-30

SchureMed announced today plans to present their newest and most innovative surgical positioning device at the AORN Show at McCormick Place in Chicago IL. The Schure Loc XPS Extremity Positioning System advances surgical patient positioning by combining both absolute rigid fixation of the patient's limb with unlimited range of motion both pre- and intra-operatively during shoulder arthroscopy, rotator cuff and total shoulder replacement procedures. Unlike other devices that use bulky hydraulic systems and supplementary power units, the Schure Loc XPS employs an ingenious ...

Texas Based Modern Intellects Artist Gift Releases The Trip EP

2014-03-29

The release of Gift's EP "The Trip" has been eagerly awaited by fans since mid-2013, the uniquely creative video countdown gave fans but a glimpse inside the mind of the independent rapper and the creative process of the project, leaving listeners and viewers wanting more. Gift first began writing at 16 years old after a serious hamstring injury that ended his future in track and field, but ended up being what would pave the way for his future. Fans have the choice of downloading the EP for free or making a donation by visiting www.giftrapsmusic.com or the artist's SoundCloud ...

Relaxed blood pressure guidelines cut millions from needing medication

2014-03-29

DURHAM, N.C. – New guidelines that ease the recommended blood pressure could result in 5.8 million U.S. adults no longer needing hypertension medication, according to an analysis by Duke Medicine researchers. The findings are the first peer-reviewed analysis to quantify the impact of guidelines announced in February by the Eighth Joint National Committee. In a divisive move, the committee relaxed the blood pressure goal in adults 60 years and older to 150/90, instead of the previous goal of 140/90. Blood pressure goals were also eased for adults with diabetes and kidney ...

Study estimates proportion of adults affected by new blood pressure guideline

2014-03-29

Applying the updated 2014 blood pressure (BP) guideline to the U.S. population suggests that nearly 6 million adults are no longer classified as needing hypertension medication, and that an estimated 13.5 million adults would now be considered as having achieved goal blood pressure, primarily older adults, according to a JAMA study released online to coincide with the 2014 American College of Cardiology Scientific Sessions. Ann Marie Navar-Boggan, M.D., Ph.D., of Duke University Medical Center, Durham, N.C., and colleagues quantified the proportion of adults potentially ...

US, European cholesterol guidelines differ in statin use recommendations

2014-03-29

Application of U.S. and European cholesterol guidelines to a European population found that proportions of individuals eligible for statins differed substantially, with one U.S. guideline recommending statins for nearly all men and two-thirds of women, proportions exceeding those of the other guidelines, according to a JAMA study released online to coincide with the 2014 American College of Cardiology Scientific Sessions. The common approach in cardiovascular disease (CVD) primary prevention is to identify individuals at high enough risk to justify more intensive lifestyle ...

LAST 30 PRESS RELEASES:

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC